|
US2012237480A1
|
|
2′allene-substituted nucleoside derivatives
|
|
US2011218175A1
|
|
Antiviral agents
|
|
US2011206637A1
|
|
Antiviral agents
|
|
US2011064698A1
|
|
Hepatitis C virus inhibitors
|
|
US2011070197A1
|
|
Hepatitis C virus inhibitors
|
|
US2011064696A1
|
|
Hepatitis C virus inhibitors
|
|
US2011008288A1
|
|
Hepatitis C virus inhibitors
|
|
US2010316607A1
|
|
Hepatitis C virus inhibitors
|
|
US2010260715A1
|
|
Hepatitis C virus inhibitors
|
|
US2010209390A1
|
|
Cyclosporin analogues
|
|
US2010221216A1
|
|
Hepatitis C Virus inhibitors
|
|
US2010226882A1
|
|
Linked diimidazole antivirals
|
|
US2010221214A1
|
|
Linked dibenzimidazole derivatives
|
|
US2010135960A1
|
|
Antiviral acylsulfonamide derivatives
|
|
US2010074863A1
|
|
Anti-infective pyrrolidine derivatives and analogs
|
|
US2009326019A1
|
|
3,4-bicyclic pyrrolidine antivirals
|
|
US2009274686A1
|
|
Nucleoside phosphonate derivatives
|
|
US2009233972A1
|
|
Substituted heterocycles as anti-infectives
|
|
US2009053175A1
|
|
Substitute pyrrolidine derivatives
|
|
US2009022689A1
|
|
C4-spiro-pyrrolidine antivirals
|
